Six years after Japan's Daiichi Sankyo acquired Ranbaxy Laboratories in June 2008, it has handed over the reins of company to India's distressed asset turnaround specialist and Sun Pharma founder, Dilip Shanghvi.
written on 07.04.2014
India's turnaround specialist Sun snaps Ranbaxy in $4bn deal
